Antihyperglycemic and antidyslipidemic agent from Aegle marmelos

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 6, 2007, Pages 1808-1811

  Narender, T ^a   Shweta, S ^a   Tiwari, P ^a   Papi Reddy, K ^a   Khaliq, T ^a   Prathipati, P ^a   Puri, A ^a   Srivastava, A K ^a   Chander, R ^a   Agarwal, S C ^a   Raj, K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

3 AR agonist activity; Aegeline; Aegle marmelos; Antidyslipidemic activity; Antihyperglycemic activity

Indexed keywords

AEGELINE; AEGLE MARMELOS EXTRACT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; FATTY ACID; SUCROSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HAMSTER; MALE; MOUSE; NONHUMAN; PLANT LEAF; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENERGIC BETA-3 RECEPTOR AGONISTS; ADRENERGIC BETA-AGONISTS; AEGLE; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MALE; MODELS, MOLECULAR; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

AEGLE MARMELOS; CRICETINAE; RATTUS; RUTACEAE;

EID: 33847073003     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.12.037     Document Type: Article

References (56)

1. King H., and Rewers M. Diabetes Care 16 (1993) 157
2. McCarthy D., and Zimmet P. Diabetes 1994 to 2010 Global Estimates and Projections (1994), International Diabetes Institute, Melbourne
3. Bennett P.H. Diabetes Metab. Rev. 13 (1997) 583
4. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Diabetologia 34 (1991) 416
5. Eghdamian E., and Ghose K. Drugs Today 34 (1998) 943
6. Bloom J.D., Dutia M.D., Johnson B.D., Wissner A., Burns M.G., Largis E.E., Dolan J.A., and Claus T.H. J. Med. Chem. 35 (1992) 3081
7. Fowden L., Pratt H.M., and Smith A. Phytochemistry 12 (1973) 1707
8. Christophe B., Manteghetti M., Gross R., Baissac Y., Jacob M., Petit P., Sauvaire Y., and Ribes G. Eur. J. Pharma 390 (2000) 339
9. Narender T., Anju P., Shweta, Tanvir K., Rashmi S., Bhatia G., and Chander R. Bio-org. Med. Chem. Lett. 16 (2006) 293
10. Hassall C.H., and Reyle K. Biochem. J. 60 (1955) 334
11. Hassall C.H., Reyle K., and Feng P. Nature (Lond.) 173 (1954) 356
12. Jane M., Melville G.N., Bennett C., West M., and Castro A. Biochem. Pharmacol. 36 (1987) 495
13. Hassall C.H., and John D.I. J. Chem. Soc. (1960) 4112
14. Werner E.A., and Bell J. J. Chem. Soc. 221 (1922) 1790
15. Shapiro S.L., Parrino V.A., and Freedman L. J. Am. Chem. Soc. 81 (1959) 3728
16. Bailey C.T. Diabetic Care 12 (1989) 553
17. Deslypere J.P. Curr. Ther. Res. 56 (1995) 111
18. McClellan K.J. Drugs 55 (1998) 415
19. Yamamoto A., Yamamura T., Yokoyama S., Sudo H., and Matsuzara Y. Int. J. Clin. Pharmacol. Ther. Toxicol. 22 (1984) 493
20. McCarthy P.A., Deivinno M.P., and Morchouse L.A. J. Med. Chem. 39 (1996) 1935
21. Bang H.O., Dyerberg J., and Nielsen A.B. Lancet 1 (1971) 1143
22. Bang H.O., and Dyerberg J. Acta Med. Scand. 192 (1972) 85
23. Bang H.O., Dyerberg J., and Hjorne N. Acta Med. Scand. 200 (1975) 69
24. Kirtikar, B. D.; Basu, K. R. Indian medicinal plants Part I, 1993.
25. Karunanayake E.H., Welihinda J., Sirimanne S.R., and Sinnadoral G. J. Ethnopharmacol. 11 (1984) 223
26. Ponnachan P.T., Paulose C.S., and Panikkar K.R. Indian J. Exp. Biol. 31 (1993) 354
27. Seema P.V., Sudha B., Padayatti P.S., Abraham A., Raghu K.G., and Paulose C.S. Indian J. Exp. Biol. 34 (1996) 600
28. Dhallval, K. S. U.S. Patent 5886029, 1999.
29. Sachdeva A., et al. J. Environ. Biol. 22 (2001) 53
30. Kar A., Chaudary B.K., and Bandyopadyay N.G. J. Ethnopharmacol. 84 (2003) 105
31. Puri, A.; Shweta; Gufran, A.; Maurya, R.; Agarwal, S. C.; Bhatia, G.; Chander, R., Narender, T. J. Herb. Pharmacother. in press.
32. Chatterjee A., Bose S., and Srimay S.K. J. Org. Chem. 24 (1959) 687
33. Rizvi R., Puri A., Bhatia G., Khanna A.K., Wulf E.M., Rastogi A.K., and Chander R. Biochem. Biophys. Res. Commun. 305 (2003) 215
34. Bhatia G., Rizvi F., Saxena R., Puri A., Khanna A.K., Chander R., Wulf E.M., Chander R., and Rastogi A.K. Indian J. Exp. Biol. 41 (2003) 1456
35. Buccolo G., and David H. Clin. Chem. 29 (1973) 1798
36. Deeg R., and Ziegenhorn J. Clin. Chem. 29 (1983) 476
37. Gordon D.J., Probstfield J.L., Garrison R.J., Neatom J.D., Jacob D.R., Bangdiwala Jr. S., and Tyroler H.A. Circulation 79 (1989) 8
38. Gowan M.W., Artiss J.D., Strandbergh D.R., and Zak B. Clin. Chem. 29 (1983) 538
39. Wako pure Chemical Limited. NAFAC, Company code No. 994-75409E.
40. Issemann I., and Green S. Nature 347 (1990) 645
41. Goldstein B.J., Bittner-Kowalczyk A., White M.F., and Harbeck M. J. Biol. Chem. 275 (2000) 4283
42. Mills, J.; Schmiegel, K. K.; Shaw, W. N. Eur. Patent No. 7204, 1979.
43. Shaw W.N., Schmiegel K.K., Yen T.T., Toomey R.E., Meyers D.B., and Mills J. Life Sci. 29 (1981) 2091
44. Yen T.T. Int. J. Obesity 8 (1984) 69
45. Mills, J.; Schmiegel, K. K.; Tuttle, R. R. US Patent Appl. No. 4,391,826, 1979.
46. Yen T.T., McKee M.M., and Stamm N.B. Int. J. Obesity 8 (1984) 65
47. Triscari J., Tilley T., and Hogan S. Ann. Rep. Med. Chem. 23 (1988) 191
48. Largis E.E., Burns M.G., Muenkel H.A., Dolan J.A., and Claus T.H. Drug Dev. Res. 32 (1994) 69
49. Bloom J.D., and Claus T.H. Drugs Future 19 (1994) 23
50. Dolan J.A., Muenkel H.A., Burns M.G., Pelligrino S.M., Fraser C.M., Pietri F., Strosberg A.D., and Largis E.E. J. Pharmacol. Exp. Ther. 269 (1994) 1000
51. Howe R. Drugs Future 18 (1993) 529
52. Arch J.R.S., and Kaumann A. J. Med. Res. Rev. 13 (1993) 663
53. 3-adrenergic agonism; Futura publishing Armonk, 1995.
54. Kordic C.P., and Reitz A.B. J. Med. Chem. 42 (1999) 181
55. Washburn W.N., Sher P.M., Poss K.M., Girotra R.N., et al. Bioorg. Med. Chem. Lett. 11 (2001) 3035
56. Prathipati P., and Saxena A.K. J. Comput. Aided Drug Des. 19 (2005) 93